Biomatrica
San Diego, US · Delaware corporation · 1 known investors
Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology. Its work centers on cancer screening tests such as a multi-target stool DNA test for colorectal cancer.
Founders & leadership
TB
Tony BroadNamed on SEC filing
FF
Francois FerreNamed on SEC filing
NE
Nick EcosNamed on SEC filing
JM
Joseph MarkeeNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 1 round · 2017
▶$18.1MraisedDec 2017 · 18 investors · BiotechnologyRule 506(b)
▶$18.1MraisedDec 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tony BroadExecutive Officer
- Francois FerreDirector
- Nick EcosExecutive Officer, Director
- Joseph MarkeeExecutive Officer, Director
- Offering amount
- $21.1M
- Amount sold
- $18.1M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Biomatrica do?
- Exact Sciences develops and runs laboratory tests and clinical studies for cancer detection and treatment, serving patients and health care professionals in oncology. Its work centers on cancer screening tests such as a multi-target stool DNA test for colorectal cancer.
- Who are Biomatrica's investors?
- Biomatrica's investors include BioBrit.
- How much funding has Biomatrica raised?
- Biomatrica has disclosed $18.1M raised across 1 round.
- Where is Biomatrica headquartered?
- Biomatrica is headquartered in San Diego, US.